Literature DB >> 31863406

One-Day Acceptance and Commitment Therapy Compared to Support for Depressed Migraine Patients: a Randomized Clinical Trial.

Lilian N Dindo1,2, Ana Recober3, Chadi A Calarge4,5, Bridget M Zimmerman6, Aliza Weinrib7, James N Marchman8, Carolyn Turvey9.   

Abstract

In patients with migraine, depression is associated with poorer medical prognosis, decreased quality of life, and increased risk of suicidality and disability; yet, behavioral interventions have rarely been investigated. The current study compared the efficacy of two 1-day (5- to 6-h) interventions for co-occurring migraine and depression: (1) acceptance and commitment therapy plus migraine education (ACT-ED), and (2) support plus migraine education (S-ED). One hundred and thirty-six patients with comorbid depression and migraine were randomized to a treatment. One hundred and three (76%) completed the ACT-ED (N = 56) or S-ED (N = 47) workshop. Primary outcomes were depression diagnosis and symptoms. Secondary outcomes were anxiety symptoms, headache-related disability and general functioning, and quality of life. Assessments were completed at baseline and 3 and 6 months following the workshop. At the 6-month follow-up, on categorical outcomes, a significantly greater number of people in the ACT-ED condition no longer met criteria for a major depressive episode and exhibited a > 50% drop in symptoms on the Hamilton Rating Scale of Depression. Similarly, though, weaker results were found when examining depressive symptoms dimensionally. On secondary outcomes, people in the ACT-ED condition exhibited significantly greater improvements in anxiety, headache-related disability, and quality of social relationships, compared to S-ED, No differences between groups were observed in general functioning. A 1-day (5- to 6-h) ACT workshop can deliver substantial and lasting benefits to depressed migraineurs, over and above those provided by group support and education. This approach is an attractive alternative to weekly psychotherapy. Clinicaltrials.gov # NCT02108678.

Entities:  

Keywords:  Acceptance and commitment therapy (ACT); Depression; Illness management; Migraine

Mesh:

Year:  2020        PMID: 31863406      PMCID: PMC7283406          DOI: 10.1007/s13311-019-00818-0

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   7.620


  38 in total

Review 1.  Considering Meta-Analysis, Meaning, and Metaphor: A Systematic Review and Critical Examination of "Third Wave" Cognitive and Behavioral Therapies.

Authors:  Sona Dimidjian; Joanna J Arch; Rebecca L Schneider; Philip Desormeau; Jennifer N Felder; Zindel V Segal
Journal:  Behav Ther       Date:  2016-07-14

2.  Psychiatric comorbidity of migraine.

Authors:  Sandra W Hamelsky; Richard B Lipton
Journal:  Headache       Date:  2006-10       Impact factor: 5.887

Review 3.  Acceptance and Commitment Therapy: A Transdiagnostic Behavioral Intervention for Mental Health and Medical Conditions.

Authors:  Lilian Dindo; Julia R Van Liew; Joanna J Arch
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

4.  Prevalence and burden of migraine in the United States: data from the American Migraine Study II.

Authors:  R B Lipton; W F Stewart; S Diamond; M L Diamond; M Reed
Journal:  Headache       Date:  2001 Jul-Aug       Impact factor: 5.887

5.  Headache and psychiatric comorbidity: historical context, clinical implications, and research relevance.

Authors:  Alvin E Lake; Jeanetta C Rains; Donald B Penzien; Gay L Lipchik
Journal:  Headache       Date:  2005-05       Impact factor: 5.887

6.  Depression and anxiety associated with three pain conditions: results from a nationally representative sample.

Authors:  Lachlan A McWilliams; Renee D Goodwin; Brian J Cox
Journal:  Pain       Date:  2004-09       Impact factor: 6.961

Review 7.  The epidemiology, burden, and comorbidities of migraine.

Authors:  Marcelo E Bigal; Richard B Lipton
Journal:  Neurol Clin       Date:  2009-05       Impact factor: 3.806

8.  Comorbidity of migraine and psychiatric disorders--a national population-based study.

Authors:  Nathalie Jette; Scott Patten; Jeanne Williams; Werner Becker; Samuel Wiebe
Journal:  Headache       Date:  2007-12-07       Impact factor: 5.887

9.  The medical costs of migraine and comorbid anxiety and depression.

Authors:  Jacqueline Pesa; Maureen J Lage
Journal:  Headache       Date:  2004-06       Impact factor: 5.887

Review 10.  Assessing and managing all aspects of migraine: migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life.

Authors:  Dawn C Buse; Marcia F T Rupnow; Richard B Lipton
Journal:  Mayo Clin Proc       Date:  2009-05       Impact factor: 7.616

View more
  1 in total

1.  Single-Session Acceptance and Commitment Therapy (ACT) Interventions for Patients with Chronic Health Conditions: A Systematic Review and Meta-Analysis.

Authors:  Cara Dochat; Jennalee S Wooldridge; Matthew S Herbert; Michael W Lee; Niloofar Afari
Journal:  J Contextual Behav Sci       Date:  2021-03-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.